Evidence map›Paper›PMID 31787617›Full record

ArticleHaematologica2019

The role of nuclear receptor co-activator 4 in erythropoiesis (Reply to Nai

Naiara Santana-Codina, Sebastian Gableske, Mark D. Fleming, J. Wade Harper, Alec C. Kimmelman, Joseph D. Mancias

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Role of Nuclear Receptors in Controlling Erythropoiesis.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Naiara Santana-CodinaDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.
Sebastian GableskeDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.
Mark D. FlemingDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, 320 Longwood Avenue, Boston, MA.
J. Wade HarperDepartment of Cell Biology, Harvard Medical School, Boston, MA and wade_harper@hms.harvard.edu.
Alec C. KimmelmanDepartment of Radiation Oncology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA Alec.Kimmelman@nyumc.org.
Joseph D. ManciasDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA; Joseph_Mancias@dfci.harvard.edu.

Funding

Network organization of the human autophagy systemR01GM095567 · NIGMS · HARVARD MEDICAL SCHOOL · PI HARPER, JEFFREY W, KIMMELMAN, ALEC · 2011 to 2018
$3.0M
NIGMS NIH HHS R01 GM095567
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ErythropoiesisReceptors, Cytoplasmic and NuclearAnimalsCell NucleusMiceNuclear Receptor CoactivatorsTranscription FactorsNcoA4 protein, mouseNuclear Receptor CoactivatorsReceptors, Cytoplasmic and NuclearTranscription Factors

Identifiers

PMID31787617
PMCPMC6959188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.